No Data
Express News | Orgenesis Inc: Pursuant to Deal, for Purchase of Assets, Co to Pay Theracell $13 Mln
Express News | Orgenesis Inc: Entered Purchase Deal With Theracell for Purchase of 50% Outstanding Ownership Rights & Equity Interests in Theracell Laboratories Ike
Orgenesis Enters Asset Purchase Agreement With Broaden Bioscience For CAR-T Processing Assets; Will Pay Up To $11M Based On Third Party Valuation; Payment Exceeding $10.77M Debt May Be Made In Shares Or A Note With 24-Month Amortization
Orgenesis Announces Board Reshuffle and New Audit Member
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Express News | Orgenesis : Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 to Regain Compliance With Bid Price and Equity Rules
No Data